Literature DB >> 24727122

TACE vs. surgical resection for BCLC stage B HCC.

Sasan Roayaie1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24727122     DOI: 10.1016/j.jhep.2014.04.005

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  11 in total

1.  Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.

Authors:  Rusi Zhang; Lujun Shen; Long Zhao; Zhaoming Guan; Qifeng Chen; Wang Li
Journal:  Diagn Interv Radiol       Date:  2018-07       Impact factor: 2.630

Review 2.  Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma.

Authors:  Zhi-Hui Gao; Dou-Sheng Bai; Guo-Qing Jiang; Sheng-Jie Jin
Journal:  World J Hepatol       Date:  2015-01-27

3.  Multiple hepatocellular carcinomas: liver resection or transcatheter arterial chemoembolization?

Authors:  Yin Lei; Lau Wan Yee; Wei-Ping Zhou
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

Review 4.  Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis.

Authors:  Wei Liu; Jian-Guo Zhou; Yi Sun; Lei Zhang; Bao-Cai Xing
Journal:  J Gastrointest Surg       Date:  2015-05-06       Impact factor: 3.452

5.  Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.

Authors:  Chetana Lim; Philippe Compagnon; Mylène Sebagh; Chady Salloum; Julien Calderaro; Alain Luciani; Gérard Pascal; Alexis Laurent; Eric Levesque; Umberto Maggi; Cyrille Feray; Daniel Cherqui; Denis Castaing; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2015-05-16       Impact factor: 3.647

6.  Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma.

Authors:  Lei Zhuang; Tianfu Wen; Mingqing Xu; Jiayin Yang; Wentao Wang; Hong Wu; Yong Zeng; Lvnan Yan; Yonggang Wei; Bo Li
Journal:  Arch Med Sci       Date:  2017-10-31       Impact factor: 3.318

7.  Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.

Authors:  Yong-Fa Zhang; Ming Shi; Liang-He Lu; Lu Wang; Rong-Ping Guo
Journal:  J Hepatocell Carcinoma       Date:  2021-04-19

8.  Ribosomal Protein L23 Drives the Metastasis of Hepatocellular Carcinoma via Upregulating MMP9.

Authors:  Minli Yang; Yujiao Zhou; Haijun Deng; Hongzhong Zhou; Shengtao Cheng; Dapeng Zhang; Xin He; Li Mai; Yao Chen; Juan Chen
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

Review 9.  Surgical Treatment of Hepatocellular Carcinoma.

Authors:  Daniel Zamora-Valdes; Timucin Taner; David M Nagorney
Journal:  Cancer Control       Date:  2017 Jul-Sep       Impact factor: 3.302

10.  The effects of patient cost sharing on inpatient utilization, cost, and outcome.

Authors:  Yuan Xu; Ning Li; Mingshan Lu; Elijah Dixon; Robert P Myers; Rachel J Jolley; Hude Quan
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.